These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7861655)

  • 1. Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.
    Hirouchi Y; Naganuma H; Kawahara Y; Okada R; Kamiya A; Inui K; Hori R
    Jpn J Pharmacol; 1994 Sep; 66(1):1-6. PubMed ID: 7861655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thienamycin nephrotoxicity. Mitochondrial injury and oxidative effects of imipenem in the rabbit kidney.
    Tune BM; Fravert D; Hsu CY
    Biochem Pharmacol; 1989 Nov; 38(21):3779-83. PubMed ID: 2597171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of a new carbapenem, panipenem/betamipron.
    Shimada J; Kawahara Y
    Drugs Exp Clin Res; 1994; 20(6):241-5. PubMed ID: 7758396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety evaluation of meropenem in animals: studies on the kidney.
    Topham JC; Murgatroyd LB; Jones DV; Goonetilleke UR; Wright J
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():287-306. PubMed ID: 2681127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.
    Ohashi N; Uematsu T; Nagashima S; Kanamaru M; Tajima N; Togawa A; Hishida A
    J Infect Chemother; 2005 Feb; 11(1):24-31. PubMed ID: 15729484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxic and peroxidative potential of meropenem and imipenem/cilastatin in rat and human renal cortical slices and microsomes.
    Yousif T; Pooyeh S; Hannemann J; Baumann J; Tauber R; Baumann K
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):475-86. PubMed ID: 10543314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031.
    Kim JM; Ha JR; Oh SW; Kim HG; Lee JM; Kim BO; Lee DG; Lee SH; Kim JG
    J Microbiol Biotechnol; 2008 Nov; 18(11):1768-72. PubMed ID: 19047819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits.
    Kim SH; Kim WB; Kwon JW; Lee MG
    Biopharm Drug Dispos; 1999 Apr; 20(3):125-9. PubMed ID: 10211864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity of panipenem/betamipron, a new carbapenem, in rabbits: correlation to concentration in central nervous system.
    Kurihara A; Hisaoka M; Mikuni N; Kamoshida K
    J Pharmacobiodyn; 1992 Jul; 15(7):325-32. PubMed ID: 1447679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of betamipron on renal toxicity during repeated cisplatin administration in rats and protective mechanism.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Ren Fail; 1998 Jan; 20(1):27-38. PubMed ID: 9509558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of N-acyl amino acids (NAAs) on cephaloridine (CER) nephrotoxicity in rabbits.
    Hirouchi Y; Naganuma H; Kawahara Y; Okada R; Kamiya A; Inui K; Hori R
    Jpn J Pharmacol; 1993 Dec; 63(4):487-93. PubMed ID: 7509889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of morin on the imipenem-induced nephrotoxicity in rabbits.
    Lim SC; Im YB; Bae CS; Han SI; Kim SE; Han HK
    Arch Pharm Res; 2008 Aug; 31(8):1060-5. PubMed ID: 18787798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low convulsive activity of a new carbapenem antibiotic, DK-35C, as compared with existing congeners.
    Jin C; Jung I; Ku HJ; Yook J; Kim DH; Kim M; Cho JH; Oh CH
    Toxicology; 1999 Nov; 138(2):59-67. PubMed ID: 10576583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem: evidence of lack of proconvulsive tendency in mice.
    Patel JB; Giles RE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():307-9. PubMed ID: 2808213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation on administration method of carbapenems].
    Mikamo H; Ninomiya M; Tamaya T
    Jpn J Antibiot; 2002 Dec; 55(6):875-81. PubMed ID: 12621741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex.
    Hikida M; Kawashima K; Yoshida M; Mitsuhashi S
    J Antimicrob Chemother; 1992 Aug; 30(2):129-34. PubMed ID: 1301069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panipenem/betamipron.
    Goa KL; Noble S
    Drugs; 2003; 63(9):913-25; discussion 926. PubMed ID: 12678575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrotoxicity and drug interaction of vancomycin].
    Toyoguchi T; Nakagawa Y; Watanabe H
    Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective cohort study of panipenem/betamipron for adult pneumococcal bacteremia at three teaching hospitals in Japan.
    Suzuki H; Tokuda Y; Shichi D; Hitomi S; Ishikawa H; Maeno T; Nakamura H
    J Infect Chemother; 2013 Aug; 19(4):607-14. PubMed ID: 23203218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
    Horiuchi M; Kimura M; Tokumura M; Hasebe N; Arai T; Abe K
    Toxicology; 2006 May; 222(1-2):114-24. PubMed ID: 16549226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.